Tag: biosimilars

Generics vs Brand Biologics: Cost Difference Comparison
21 Aug, 2026

Generics vs Brand Biologics: Cost Difference Comparison

by Trevor Ockley | Aug, 21 2026 | Health | 0 Comments

Discover the significant cost difference between brand biologics and biosimilars. Learn how switching can save you up to 80% on medications like Humira and what factors influence these prices.

Continue Reading
Clinical Outcomes with Biosimilars: Do They Work as Well as Reference Drugs?
9 Jun, 2026

Clinical Outcomes with Biosimilars: Do They Work as Well as Reference Drugs?

by Trevor Ockley | Jun, 9 2026 | Health | 0 Comments

Explore whether biosimilars work as well as reference biologics. We analyze clinical data, safety profiles, and patient experiences to answer key questions about effectiveness and cost.

Continue Reading
How to Use the FDA Orange Book and Purple Book for Drug Safety Information
28 Jan, 2026

How to Use the FDA Orange Book and Purple Book for Drug Safety Information

by Trevor Ockley | Jan, 28 2026 | Health | 15 Comments

Learn how to use the FDA Orange Book and Purple Book to verify drug safety, spot withdrawn medications, and check biosimilar equivalence. Essential for pharmacists, clinicians, and patients.

Continue Reading
When Can Biosimilars Be Automatically Substituted? U.S. Rules Explained
18 Jan, 2026

When Can Biosimilars Be Automatically Substituted? U.S. Rules Explained

by Trevor Ockley | Jan, 18 2026 | Health | 10 Comments

In the U.S., only certain biosimilars are designated as interchangeable by the FDA, allowing pharmacists to swap them for brand-name biologics without a doctor’s approval. Learn how it works, which ones qualify, and why state laws make it complicated.

Continue Reading